Sudeep Pharma Limited (BOM:544619)
1,166.85
+8.75 (0.76%)
At close: Oct 7, 2026
Sudeep Pharma Revenue
Sudeep Pharma had revenue of 1.58B INR in the quarter ending June 30, 2026, with 26.70% growth. This brings the company's revenue in the last twelve months to 6.76B, up 31.84% year-over-year. In the fiscal year ending March 31, 2026, Sudeep Pharma had annual revenue of 6.42B with 27.94% growth.
Revenue (ttm)
6.76B
Revenue Growth
+31.84%
P/S Ratio
19.37
Revenue / Employee
12.87M
Employees
525
Market Cap
131.83B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2026 | 6.42B | 1.40B | 27.94% |
| Mar 31, 2025 | 5.02B | 427.19M | 9.30% |
| Mar 31, 2024 | 4.59B | 305.42M | 7.12% |
| Mar 31, 2023 | 4.29B | 841.21M | 24.41% |
| Mar 31, 2022 | 3.45B | 3.38B | 4,999.06% |
| Mar 31, 2004 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2003 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| IOL Chemicals and Pharmaceuticals | 25.24B |
| Neuland Laboratories | 23.72B |
| Shilpa Medicare | 16.83B |
| Symbiotec Pharmalab | 8.84B |
| Bajaj HealthCare | 6.28B |
| NGL Fine-Chem | 5.36B |
| Aarey Drugs & Pharmaceuticals | 4.15B |
| Gujarat Themis Biosyn | 1.74B |
Sudeep Pharma News
- 2 months ago - Sudeep Pharma Quarterly report: Q1 2027 - Filings
- 2 months ago - Sudeep Pharma Slides: Q1 2027 - Filings
- 4 months ago - Sudeep Pharma Quarterly report: Q4 2026 - Filings
- 4 months ago - Sudeep Pharma Slides: Q4 2026 - Filings
- 4 months ago - Sudeep Pharma Annual report: Q4 2026 - Filings
- 8 months ago - Sudeep Pharma Quarterly report: Q3 2026 - Filings
- 8 months ago - Sudeep Pharma Slides: Q3 2026 - Filings
- 9 months ago - Sudeep Pharma Quarterly report: Q2 2026 - Filings